• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血液透析患者不同骨标志物的评估

Evaluation of different bone markers in hemodialyzed patients.

作者信息

Cavalier Etienne, Delanaye Pierre, Collette Julien, Krzesinski Jean-Marie, Chapelle Jean-Paul

机构信息

Department of Clinical Chemistry, University Hospital of Liege, University of Liege, B-35 Domaine du Sart-Tilman, B-4000 Liege, Belgium.

出版信息

Clin Chim Acta. 2006 Sep;371(1-2):107-11. doi: 10.1016/j.cca.2006.02.029. Epub 2006 Mar 2.

DOI:10.1016/j.cca.2006.02.029
PMID:16600202
Abstract

BACKGROUND

Routinely, nephrologists rely on different biochemical markers like intact PTH (iPTH), bone-specific alkaline phosphatase (BALP), plasmatic calcium and phosphate. The aim of the present study was to evaluate different other bone markers like N-terminal propeptide of type 1 procollagen (P1NP), active isoform 5b of the tartrate-resistant acid phosphatase (TRAP 5b) and beta-crossLaps (CTXS) as well as full-length PTH (wPTH), presumed non-(1-84) PTH, and their ratio in the diagnosis of renal osteodystrophy with high and low turnover. We also determined 25 hydroxyvitamin D (25VTD), 1-25 dihydroxyvitamin D and homocystein (HCY).

METHODS

We performed those parameters on 73 patients with end-stage renal disease according to the manufacturers' instructions.

RESULTS

There were very strong correlations between the bone markers concentrations, particularly between BALP and P1NP (r=0.953). We did not observe any correlation between the ratio whole PTH/non-(1-84) PTH and any of the usual bone markers. This ratio was significantly (p<0.05) higher in low and high bone turnover patients than in normal patients according to the K/DOQI. We found a correlation between low levels of 25VTD and high levels of HCY.

CONCLUSIONS

BALP offers the best clinical and analytical profile as the easier marker of choice in hemodialyzed patients for the diagnosis of bone disease.

摘要

背景

通常,肾病学家依赖不同的生化标志物,如完整甲状旁腺激素(iPTH)、骨特异性碱性磷酸酶(BALP)、血浆钙和磷。本研究的目的是评估其他不同的骨标志物,如I型前胶原N端前肽(P1NP)、抗酒石酸酸性磷酸酶活性异构体5b(TRAP 5b)和β-交联C端肽(CTXS),以及全长甲状旁腺激素(wPTH)、推测的非(1-84)甲状旁腺激素及其比值,以诊断高转换型和低转换型肾性骨营养不良。我们还测定了25羟维生素D(25VTD)、1,25二羟维生素D和同型半胱氨酸(HCY)。

方法

我们按照制造商的说明,对73例终末期肾病患者进行了这些参数的检测。

结果

骨标志物浓度之间存在非常强的相关性,尤其是BALP和P1NP之间(r=0.953)。我们未观察到全甲状旁腺激素/非(1-84)甲状旁腺激素比值与任何常见骨标志物之间存在相关性。根据K/DOQI标准,低骨转换和高骨转换患者的该比值显著高于正常患者(p<0.05)。我们发现25VTD水平低与HCY水平高之间存在相关性。

结论

BALP具有最佳的临床和分析特征,是血液透析患者诊断骨病时更容易选择的标志物。

相似文献

1
Evaluation of different bone markers in hemodialyzed patients.血液透析患者不同骨标志物的评估
Clin Chim Acta. 2006 Sep;371(1-2):107-11. doi: 10.1016/j.cca.2006.02.029. Epub 2006 Mar 2.
2
Tartrate-resistant acid phosphatase 5b and its correlations with other markers of bone metabolism in kidney transplant recipients and dialyzed patients.抗酒石酸酸性磷酸酶5b及其与肾移植受者和透析患者骨代谢其他标志物的相关性。
Adv Med Sci. 2006;51:69-72.
3
Bone markers in the diagnosis of low turnover osteodystrophy in haemodialysis patients.骨标志物在血液透析患者低转换型骨营养不良诊断中的应用
Nephrol Dial Transplant. 1998 Sep;13(9):2294-302. doi: 10.1093/ndt/13.9.2294.
4
[Tartrate-resistant acid phosphatase--TRAP 5b--as a novel marker of bone resorption in patients with irreversible renal failure treated with dialysis].[抗酒石酸酸性磷酸酶——TRAP 5b——作为接受透析治疗的不可逆肾衰竭患者骨吸收的新型标志物]
Pol Merkur Lekarski. 2004 Aug;17(98):138-41.
5
Bone alkaline phosphatase isoforms in hemodialysis patients with low versus non-low bone turnover: a diagnostic test study.骨转换率低与非低的血液透析患者的骨碱性磷酸酶同工型:一项诊断试验研究
Am J Kidney Dis. 2015 Jul;66(1):99-105. doi: 10.1053/j.ajkd.2015.02.323. Epub 2015 Apr 2.
6
Diagnostic Accuracy of Bone Turnover Markers and Bone Histology in Patients With CKD Treated by Dialysis.透析治疗的慢性肾脏病患者骨转换标志物和骨组织学的诊断准确性。
Am J Kidney Dis. 2016 Apr;67(4):559-66. doi: 10.1053/j.ajkd.2015.06.023. Epub 2015 Aug 25.
7
Correlations of new markers of bone formation and resorption in kidney transplant recipients.肾移植受者骨形成与骨吸收新标志物的相关性
Transplant Proc. 2003 Jun;35(4):1351-4. doi: 10.1016/s0041-1345(03)00523-2.
8
Clinical usefulness of serum carboxyterminal propeptide of procollagen I and tartrate-resistant acid phosphatase determinations to evaluate bone turnover in patients with chronic renal failure.血清Ⅰ型前胶原羧基末端前肽和抗酒石酸酸性磷酸酶测定在评估慢性肾衰竭患者骨转换中的临床应用价值
Miner Electrolyte Metab. 1994;20(5):259-64.
9
Influence of PTH assay methodology on differential diagnosis of renal bone disease.甲状旁腺激素检测方法对肾性骨病鉴别诊断的影响。
Nephrol Dial Transplant. 2003 Apr;18(4):759-68. doi: 10.1093/ndt/gfg144.
10
Correlation of bone alkaline phosphatase and iPTH with some basic biochemical markers in predialysis and dialysis patients.骨碱性磷酸酶和甲状旁腺激素与透析前及透析患者某些基本生化指标的相关性
Clin Lab. 2012;58(7-8):747-53.

引用本文的文献

1
Advances in the application of bone turnover markers for pediatric growth and developmental disorders: a review.骨转换标志物在儿童生长发育障碍中的应用进展:综述
Front Endocrinol (Lausanne). 2025 Sep 10;16:1615712. doi: 10.3389/fendo.2025.1615712. eCollection 2025.
2
Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients.甲状旁腺激素和骨生物标志物的变化只有在血液透析患者长期随访后才一致。
Sci Rep. 2017 Oct 3;7(1):12623. doi: 10.1038/s41598-017-12808-3.
3
Calcitriol resistance in hemodialysis patients with secondary hyperparathyroidism.
继发性甲状旁腺功能亢进血液透析患者的骨化三醇抵抗
Int Urol Nephrol. 2014 Jun;46(6):1145-51. doi: 10.1007/s11255-013-0637-2. Epub 2014 Jan 3.
4
Noninvasive assessment of bone health in Indian patients with chronic kidney disease.印度慢性肾脏病患者骨健康的无创评估
Indian J Nephrol. 2013 May;23(3):161-7. doi: 10.4103/0971-4065.111831.
5
Primary hyperparathyroidism associated with hypocalcemia in a patient presenting with kidney disease.原发性甲状旁腺功能亢进症伴低钙血症患者,伴发肾脏病。
Int Urol Nephrol. 2010 Sep;42(3):835-9. doi: 10.1007/s11255-010-9743-6. Epub 2010 May 7.